These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28108637)

  • 21. Longitudinal modeling of cognitive aging and the TOMM40 effect.
    Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
    Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.
    Lyall DM; Royle NA; Harris SE; Bastin ME; Maniega SM; Murray C; Lutz MW; Saunders AM; Roses AD; del Valdés Hernández MC; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    PLoS One; 2013; 8(11):e80513. PubMed ID: 24260406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex differences in associations between APOE ε2 and longitudinal cognitive decline.
    Wood ME; Xiong LY; Wong YY; Buckley RF; Swardfager W; Masellis M; Lim ASP; Nichols E; Joie R; Casaletto KB; Kumar RG; Dams-O'Connor K; Palta P; George KM; Satizabal CL; Barnes LL; Schneider JA; Binet AP; Villeneuve S; Pa J; Brickman AM; Black SE; Rabin JS;
    Alzheimers Dement; 2023 Oct; 19(10):4651-4661. PubMed ID: 36994910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.
    Cruchaga C; Nowotny P; Kauwe JS; Ridge PG; Mayo K; Bertelsen S; Hinrichs A; Fagan AM; Holtzman DM; Morris JC; Goate AM;
    Arch Neurol; 2011 Aug; 68(8):1013-9. PubMed ID: 21825236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
    Batterham PJ; Bunce D; Cherbuin N; Christensen H
    Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOE ε4 and the associations of seafood and long-chain omega-3 fatty acids with cognitive decline.
    van de Rest O; Wang Y; Barnes LL; Tangney C; Bennett DA; Morris MC
    Neurology; 2016 May; 86(22):2063-70. PubMed ID: 27164694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes.
    Greenbaum L; Springer RR; Lutz MW; Heymann A; Lubitz I; Cooper I; Kravitz E; Sano M; Roses AD; Silverman JM; Saunders AM; Beeri MS
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1492-9. PubMed ID: 25044051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population.
    Riaz M; Huq A; Ryan J; Orchard SG; Tiller J; Lockery J; Woods RL; Wolfe R; Renton AE; Goate AM; Sebra R; Schadt E; Brodtmann A; Shah RC; Storey E; Murray AM; McNeil JJ; Lacaze P
    Aging Cell; 2021 Jun; 20(6):e13384. PubMed ID: 34041846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The apolipoprotein E epsilon 2 allele and decline in episodic memory.
    Wilson RS; Bienias JL; Berry-Kravis E; Evans DA; Bennett DA
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):672-7. PubMed ID: 12438469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A large ApoE ε4/ε4 homozygous cohort reveals no association with Parkinson's disease.
    Multhammer M; Michels A; Zintl M; Mendoza MC; Klünemann HH
    Acta Neurol Belg; 2014 Mar; 114(1):25-31. PubMed ID: 23794363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein ɛ4 Carriers versus Apolipoprotein ɛ3 Homozygotes.
    Sible IJ; Nation DA;
    J Alzheimers Dis; 2023; 93(2):533-543. PubMed ID: 37066910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains.
    Smits LL; Pijnenburg YA; van der Vlies AE; Koedam EL; Bouwman FH; Reuling IE; Scheltens P; van der Flier WM
    Eur Neuropsychopharmacol; 2015 Jul; 25(7):1010-7. PubMed ID: 25891378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.
    Blue EE; Cheng A; Chen S; Yu CE;
    JAMA Netw Open; 2020 Oct; 3(10):e2017666. PubMed ID: 33090224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective association of the ε2/ε3 heterozygote with Alzheimer's disease is strengthened by TOMM40-APOE variants in men.
    Kulminski AM; Philipp I; Loika Y; He L; Culminskaya I
    Alzheimers Dement; 2021 Nov; 17(11):1779-1787. PubMed ID: 34310032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment.
    Nho K; Corneveaux JJ; Kim S; Lin H; Risacher SL; Shen L; Swaminathan S; Ramanan VK; Liu Y; Foroud T; Inlow MH; Siniard AL; Reiman RA; Aisen PS; Petersen RC; Green RC; Jack CR; Weiner MW; Baldwin CT; Lunetta K; Farrer LA; ; Furney SJ; Lovestone S; Simmons A; Mecocci P; Vellas B; Tsolaki M; Kloszewska I; Soininen H; ; McDonald BC; Farlow MR; Ghetti B; ; Huentelman MJ; Saykin AJ;
    Mol Psychiatry; 2013 Jul; 18(7):781-7. PubMed ID: 23608917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interaction of APOE genotype by age in amnestic mild cognitive impairment: a voxel-based morphometric study.
    Chen J; Shu H; Wang Z; Liu D; Shi Y; Zhang X; Zhang Z
    J Alzheimers Dis; 2015; 43(2):657-68. PubMed ID: 25114090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis.
    Gang Q; Bettencourt C; Machado PM; Fox Z; Brady S; Healy E; Parton M; Holton JL; Hilton-Jones D; Shieh PB; Zanoteli E; De Paepe B; De Bleecker J; Shaibani A; Ripolone M; Violano R; Moggio M; Barohn RJ; Dimachkie MM; Mora M; Mantegazza R; Zanotti S; Hanna MG; Houlden H;
    Neurobiol Aging; 2015 Apr; 36(4):1766.e1-1766.e3. PubMed ID: 25670332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
    Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Hurtig HI; Van Deerlin VM; Ritz B; Rausch R; Rhodes SL; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson AL; Espay AJ; Revilla FJ; Devoto J; Hu SC; Cholerton BA; Wan JY; Montine TJ; Edwards KL; Zabetian CP
    JAMA Neurol; 2014 Nov; 71(11):1405-12. PubMed ID: 25178429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study.
    Martinelli N; Olivieri O; Shen GQ; Trabetti E; Pizzolo F; Busti F; Friso S; Bassi A; Li L; Hu Y; Pignatti PF; Corrocher R; Wang QK; Girelli D
    BMC Med Genet; 2009 May; 10():41. PubMed ID: 19439088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity.
    Maruszak A; Pepłońska B; Safranow K; Chodakowska-Żebrowska M; Barcikowska M; Zekanowski C
    J Alzheimers Dis; 2012; 28(2):309-22. PubMed ID: 22008263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.